1887

Abstract

SUMMARY

At the pH optimum for membrane fusion the haemagglutinin glycoprotein (HA) of the influenza virus membrane which is implicated in the fusion activity undergoes a conformational change. We have analysed the effects of this change on the antigenicity of the haemagglutinin by reacting the molecule with monoclonal antibodies of defined specificity. The results obtained indicate that specific changes in antigenicity occur in antigenic sites B and D and are interpreted in terms of the three-dimensional structure of the molecule and the effects of low pH incubation on it. Our results also provide evidence for the antigenic significance of amino acid sequence changes in site B of the HAs of natural isolates and allow clear delineation of this site into two regions.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-8-1657
1983-08-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/8/JV0640081657.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-8-1657&mimeType=html&fmt=ahah

References

  1. Air G. M. 1981; Sequence relationships among the haemagglutinin genes of 12 subtypes of influenza A virus. Proceedings of the National Academy of Sciences, V,. S,. A 78:7639–7643
    [Google Scholar]
  2. Both G. W., Sleigh M. J. 1981; Conservation and variation in the haemagglutinins of Hong Kong subtype influenza viruses during antigenic drift. Journal of Virology 39:663–672
    [Google Scholar]
  3. Brand C. M., Skehel J. J. 1972; Crystalline antigen from the influenza virus envelope. Nature New Biology 238:145–147
    [Google Scholar]
  4. Caton A. J., Brownlee G. G., Yewdell J. W., Gerhard W. 1982; The antigenic structure of the influenza virus A/PR/8/34 haemagglutinin (HI subtype). Cell 31:417–427
    [Google Scholar]
  5. Compans R. W., Klenk H.-D. 1979; Viral membranes. In Comprehensive Virology vol 13: pp 293–407 Edited by Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
    [Google Scholar]
  6. Daniels R. S., Douglas A. R., Skehel J. J., Waterfield M. D., Wilson I. A., Wiley D. C. 1983; Studies of the influenza virus haemagglutinin in the pH 5 conformation. In The Origins of Pandemic Influenza Edited by Laver W. G. (in press)
    [Google Scholar]
  7. Fazekas De St. Groth S., Scheidegger D. 1980; Production of monoclonal antibodies: strategy and tactics. Journal of Immunological Methods 35:1–21
    [Google Scholar]
  8. Huang R. T. C., Rott R., Klenk H.-D. 1981; Influenza viruses cause hemolysis and fusion of cells. Virology 110:243–247
    [Google Scholar]
  9. Kilbourne E. D. 1969; Future influenza vaccines and the use of genetic recombinants. Bulletin of the World Health Organization 41:643–645
    [Google Scholar]
  10. Kohler G., Milstein C. 1975; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, London 256:495–497
    [Google Scholar]
  11. Kohler G., Milstein C. 1976; Derivation of specific antibody-producing tissue culture and tumour lines by cell fusion. European Journal of Immunology 6:511–519
    [Google Scholar]
  12. Laver W. G., Air G. M., Webster R. G., Gerhard W., Ward C. W., Dopheide T. A. 1979; Antigenic drift in type A influenza virus: sequence differences in the haemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. Virology 98:226–237
    [Google Scholar]
  13. Laver W. G., Air G. M., Dopheide T. A., Ward C. W. 1980; Amino acid sequence changes in the haemagglutinin of A/Hong Kong (H3N2) influenza virus during the period 1968–77. Nature, London 283:454–457
    [Google Scholar]
  14. Maeda T., Ohnishi S. I. 1980; Activation of influenza viruses by acidic media causes hemolysis and fusion of erythrocytes. FEBS Letters 122:283–287
    [Google Scholar]
  15. Patel T. P., Millican T. A., Bose C. C., Titmas R. C., Mock G. A., Eaton M. A. W. 1982; Improvements to solid phase phosphotriester synthesis of deoxyoligonucleotides. Nucleic Acids Research 10:5605–5620
    [Google Scholar]
  16. Rott R., Klenk H.D. 1977; Structure and assembly of viral envelopes. In Cell Surface Reviews pp 47–81 Edited by Poste G., Nicolson G. L. Amsterdam: North-Holland;
    [Google Scholar]
  17. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
    [Google Scholar]
  18. Schulman M., Wilde C. D., Kohler G. 1978; A better cell line for making hybridomas secreting specific antibodies. Nature, London 276:269–270
    [Google Scholar]
  19. Skehel J. J., Schild G. C. 1971; The polypeptide composition of influenza A viruses. Virology 44:396–408
    [Google Scholar]
  20. Skehel J. J., Bayley P. M., Brown E. B., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. 1982; Changes in the conformation of influenza virus haemagglutinin at the pH optimum of virus-mediated membrane fusion. Proceedings of the National Academy of Sciences, U.S.A 79:968–972
    [Google Scholar]
  21. Verhoeyen M., Fang R., Min Jou W., Devos R., Huylebroeck D., Saman E., Fiers W. 1980; Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature, London 286:771–776
    [Google Scholar]
  22. White J., Matlin K., Helenius A. 1981; Cell fusion by Semliki Forest, influenza and vesicular stomatitis virus. Journal of Cell Biology 89:674–679
    [Google Scholar]
  23. White J., Helenius A., Gething M. J. 1982; Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature, London 300:658–659
    [Google Scholar]
  24. Wiley D. C., Wilson I. A., Skehel S. J. 1981; Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature, London 289:373–378
    [Google Scholar]
  25. World Health Organization Expert Committee On Influenza 1953 World Health Organization technical reports series No 64, Geneva
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-8-1657
Loading
/content/journal/jgv/10.1099/0022-1317-64-8-1657
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error